GnRH antagonist protocol with the use of GnRH-agonist for final oocyte maturation had emerged as the most effective method of preventing early onset OHSS without cycle cancellation during the past decades [15]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.